BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12867651)

  • 1. Dengue virus type 2 NS3 protease and NS2B-NS3 protease precursor induce apoptosis.
    Shafee N; AbuBakar S
    J Gen Virol; 2003 Aug; 84(Pt 8):2191-2195. PubMed ID: 12867651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yellow fever virus NS2B-NS3 protease: charged-to-alanine mutagenesis and deletion analysis define regions important for protease complex formation and function.
    Droll DA; Krishna Murthy HM; Chambers TJ
    Virology; 2000 Sep; 275(2):335-47. PubMed ID: 10998334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
    Niyomrattanakit P; Winoyanuwattikun P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
    J Virol; 2004 Dec; 78(24):13708-16. PubMed ID: 15564480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides.
    Khumthong R; Niyomrattanakit P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
    Protein Pept Lett; 2003 Feb; 10(1):19-26. PubMed ID: 12625822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro.
    Yusof R; Clum S; Wetzel M; Murthy HM; Padmanabhan R
    J Biol Chem; 2000 Apr; 275(14):9963-9. PubMed ID: 10744671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity.
    Falgout B; Miller RH; Lai CJ
    J Virol; 1993 Apr; 67(4):2034-42. PubMed ID: 8383225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of dengue protease autocleavage at the NS2B-NS3 junction by recombinant NS3 and GST-NS2B fusion proteins.
    Wu CF; Wang SH; Sun CM; Hu ST; Syu WJ
    J Virol Methods; 2003 Dec; 114(1):45-54. PubMed ID: 14599678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD; Tripathi IP; Mishra SK
    J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous proteases.
    Jan LR; Yang CS; Trent DW; Falgout B; Lai CJ
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():573-80. PubMed ID: 7897348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cotranslational membrane insertion of the serine proteinase precursor NS2B-NS3(Pro) of dengue virus type 2 is required for efficient in vitro processing and is mediated through the hydrophobic regions of NS2B.
    Clum S; Ebner KE; Padmanabhan R
    J Biol Chem; 1997 Dec; 272(49):30715-23. PubMed ID: 9388208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis of the NS3 protease of dengue virus type 2.
    Valle RP; Falgout B
    J Virol; 1998 Jan; 72(1):624-32. PubMed ID: 9420267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyso-myristoyl phosphatidylcholine micelles sustain the activity of Dengue non-structural (NS) protein 3 protease domain fused with the full-length NS2B.
    Huang Q; Li Q; Joy J; Chen AS; Ruiz-Carrillo D; Hill J; Lescar J; Kang C
    Protein Expr Purif; 2013 Dec; 92(2):156-62. PubMed ID: 24084007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates.
    Khumthong R; Angsuthanasombat C; Panyim S; Katzenmeier G
    J Biochem Mol Biol; 2002 Mar; 35(2):206-12. PubMed ID: 12297031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K; Pianwanit S; Sippl W; Kokpol S
    J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue virus serotypic replacement of NS3 protease or helicase domain causes chimeric viral attenuation but can be recovered by a compensated mutation at helicase domain or NS2B, respectively.
    Teramoto T
    J Virol; 2023 Aug; 97(8):e0085423. PubMed ID: 37555662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins.
    Falgout B; Pethel M; Zhang YM; Lai CJ
    J Virol; 1991 May; 65(5):2467-75. PubMed ID: 2016768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
    Velmurugan D; Mythily U; Rao K
    Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
    Zhou H; Singh NJ; Kim KS
    Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of protein conformation in the processing of dengue virus type 2 nonstructural polyprotein precursor.
    Zhang L; Padmanabhan R
    Gene; 1993 Jul; 129(2):197-205. PubMed ID: 8325506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease.
    Bera AK; Kuhn RJ; Smith JL
    J Biol Chem; 2007 Apr; 282(17):12883-92. PubMed ID: 17337448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.